You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 康方生物-B績後兩連漲 市值重回200億港元 多款在研管線推進臨牀後期
格隆匯 08-25 15:55
格隆匯8月25日丨康方生物-B(9926.HK)再度拉昇漲約8%,績後2日漲幅近20%,現報24.15港元,總市值重回200億港元上方。公司23日公佈,上半年實現產品總銷售額2.97億元,扣除分銷成本1.34億元后,收入增至1.63億元,同比增長26.8%。安信證券點評稱,公司雙抗商業化順利開啟,多款在研管線推進臨牀後期。考慮到公司已上市/即將上市產品的放量潛力以及豐富的臨牀研發管線,該行認為公司未來發展前景可觀,投資評級給與買入-A級。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account